RecallHawk

ADALIMUMAB-BWWD

SAMSUNG BIOEPIS CO LTD

Summary

FDA approved ADALIMUMAB-BWWD by SAMSUNG BIOEPIS CO LTD. BLA (Biologic) approval (Manufacturing (CMC)) on 2026-04-29. INJECTABLE, INJECTION.

Details

Source

Drug Approval

External ID

BLA761059-36

Action Date

2026-04-29

Status

Approved

Category

drug

Product Code

BLA (Biologic)

Product Description

ADALIMUMAB-BWWD, INJECTABLE, INJECTION. Application: BLA761059

Context & Analysis

SAMSUNG BIOEPIS CO LTD has 5 FDA actions in our database, including 1 recall.

Frequently Asked Questions

How often does SAMSUNG BIOEPIS CO LTD have FDA actions?

SAMSUNG BIOEPIS CO LTD has 5 FDA actions in our database, including 1 recall and 0 device clearances.

Where can I find the official FDA record?

The official record is available on FDA.gov. Search for "BLA761059-36" on FDA.gov for the full record. You can also use the openFDA API to query this record programmatically.

Want to know the moment something like this happens?

Get alerts for drug

Related Actions